NeoGenomics, Inc. Loss Contingency Accrual
NeoGenomics, Inc. (NEO) had Loss Contingency Accrual of $10.00 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyAccrualAtCarryingValue · last filed 2026-07-28
- 2026-06-30: Loss Contingency Accrual $10.00M.
- 2025-12-31: Loss Contingency Accrual $11.20M.
- 2019-03-31: Loss Contingency Accrual $4.90M.
| Period end | Loss Contingency Accrual |
|---|---|
| 2026-06-30 | $10.00M 10-Q · filed 2026-07-28 |
| 2025-12-31 | $11.20M 10-Q · filed 2026-07-28 |
| 2019-03-31 | $4.90M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |